Showing results (361-370 of 395) with videos related to
Sort By:
Pageof 40
Journal of Nanobiotechnology|January 30, 2021
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike proteinQizhong Lu, Zongliang Zhang, Hexian Li, et al.Journal of Translational Medicine|January 12, 2023
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacyZongliang Zhang, Guoqing Wang, Kunhong Zhong, et al.Cancer Letters|March 1, 2024
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAbZongliang Zhang, Nian Yang, Huaqing Lu, et al.Medcomm|April 16, 2026
Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated MalignanciesNian Yang, Long Xu, Meijun Zheng, et al.Chinese Medical Journal|February 28, 2018
A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet ReactivityLei Zhang, Yi Li, Bai-Song Yang, et al.Journal of the American Chemical Society|April 13, 2026
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer ImmunotherapyHongli Chi, Yanlin Du, Wei Lv, et al.BMC Medicine|December 31, 2025
Methylmalonate accumulation contributes to myocardial vulnerability post-reperfusion: a novel therapeutic target and prognostic biomarkerShanjie Wang, JunChen Guo, Zeng Wang, et al.The Journal of Pharmacy and Pharmacology|April 27, 2017
Oestrone-targeted liposomes for mitoxantrone delivery via oestrogen receptor - synthesis, physicochemical characterization and in-vitro evaluationQiang Hao, Guoxing Xu, Yue Yang, et al.Small (Weinheim an Der Bergstrasse, Germany)|December 21, 2023
Precise Synthesis of Organic Cocrystal Alloys with Full-Spectrum Emission Characteristics for the Stepless Color Changing DisplayJing Yang, Ying-Xin Ma, Yi Zong, et al.Molecular Cancer Therapeutics|November 27, 2024
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Antitumor Efficacy in Solid TumorsZeng Wang, Meijun Zheng, Mengyao Li, et al.Pageof 40